Xiang Li
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xiang Li has a total of 78 co-authors. Here are the top co-authors by number of shared publications:
- Guangsen Zheng
Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, Guangzhou, China
4 shared publications - Guiqing Liao
Department of Oral and Maxillofacial Surgery, Hospital of Stomatology, Sun Yat-sen University, Guangzhou, China
3 shared publications Jingyuan Li
Department of Oral and Maxillofacial Surgery, Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, China
3 shared publicationsKan Li
Department of Oral and Maxillofacial Surgery, Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, China
3 shared publicationsTao Chen
State Key Laboratory of Oral Diseases and Department of Oral and Maxillofacial Surgery, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, China
3 shared publicationsHuanzhong Ji
Department of Oral and Maxillofacial Surgery, Guangdong Provincial Key Laboratory of Stomatology, Guanghua School of Stomatology, Sun Yat-sen University, China
2 shared publications
Latest Publications
- Open Access
- 14 November 2026
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
Segmental posterior maxillary advancement plus mandibular advancement enhances airway outcomes without compromising the lateral nasolabial profile in skeletal class II patients: a comparative study
Background: Segmental posterior maxillary advancement (SPMA) plus mandibular advancement (MA) is a modified maxillomandibular advancement (MMMA) approach designed to expand the upper airway while preserving the nasolabial soft-tissue profile. However, the true airway benefits from SPMA remain debated, as the airway expansion from posterior maxillary advancement may be offset by concomitant setback of anterior maxilla. Current evidence is limited to pre- and post-surgical comparisons, direct comparative evidence evaluating its airway and aesthetic outcomes against MA is still lacking. This study aimed to compare airway dimensional, aerodynamic, and functional outcomes between MA+SPMA and MA alone in patients with skeletal Class II dentomaxillofacial deformity. Methods: Fifty-two patients with skeletal Class II deformity undergoing MA alone ( n = 22) or MA+SPMA ( n = 30) were retrospectively enrolled. Pre- and 6-month postoperative CT data were assessed for airway dimensions, hard/soft-tissue landmark movements, and cephalometrics. Computational fluid dynamics (CFD) analysis was used to evaluate aerodynamic changes. Polysomnography (PSG) was performed in a subset of patients with preoperative obstructive sleep apnea (OSA) to explore functional airway outcomes. Linear regression was used to identify the contribution of skeletal movements to airway expansion. Results: The MA+SPMA group showed significantly greater increases in total airway volume, post-palatal volume, and post-PNS cross-sectional area compared to the MA group. These differences persisted in a matched-pair analysis controlling the extent of mandibular advancement. Regression analysis showed that PNS advancement was independently associated with post-palatal airway expansion. Furthermore, MA+SPMA significantly reduced simulated airway resistance and airflow velocity, particularly in the post-palatal region, whereas MA alone yielded no significant aerodynamic improvements. In the OSA subgroup, both groups achieved significant AHI reductions, with MA+SPMA demonstrating significantly greater improvement, although this finding should be interpreted as exploratory. No clinically significant adverse effects on nasolabial soft-tissue profile were observed in the MA+SPMA group. Conclusions: Adding SPMA to MA was associated with greater airway enlargement, improved aerodynamics, and potential functional benefits compared to MA alone, without compromising nasolabial soft-tissue profile. Our findings support MA+SPMA as a promising surgical alternative that may balance the airway and aesthetic outcomes in selected patients with skeletal Class II deformity. Future studies are warranted to confirm its functional benefits and identify airway risk factors across Class II patient subgroups to facilitate risk-stratified surgical decision-making.
- 14 November 2026
- Published by Springer Nature in Maxillofacial Plastic and Reconstructive Surgery
Open AccessSegmental posterior maxillary advancement plus mandibular advancement enhances airway outcomes without compromising the lateral nasolabial profile in skeletal class II patients: a comparative study
Background: Segmental posterior maxillary advancement (SPMA) plus mandibular advancement (MA) is a modified maxillomandibular advancement (MMMA) approach designed to expand the upper airway while preserving the nasolabial soft-tissue profile. However, the true airway benefits from SPMA remain debated, as the airway expansion from posterior maxillary advancement may be offset by concomitant setback of anterior maxilla. Current evidence is limited to pre- and post-surgical comparisons, direct comparative evidence evaluating its airway and aesthetic outcomes against MA is still lacking. This study aimed to compare airway dimensional, aerodynamic, and functional outcomes between MA+SPMA and MA alone in patients with skeletal Class II dentomaxillofacial deformity. Methods: Fifty-two patients with skeletal Class II deformity undergoing MA alone ( n = 22) or MA+SPMA ( n = 30) were retrospectively enrolled. Pre- and 6-month postoperative CT data were assessed for airway dimensions, hard/soft-tissue landmark movements, and cephalometrics. Computational fluid dynamics (CFD) analysis was used to evaluate aerodynamic changes. Polysomnography (PSG) was performed in a subset of patients with preoperative obstructive sleep apnea (OSA) to explore functional airway outcomes. Linear regression was used to identify the contribution of skeletal movements to airway expansion. Results: The MA+SPMA group showed significantly greater increases in total airway volume, post-palatal volume, and post-PNS cross-sectional area compared to the MA group. These differences persisted in a matched-pair analysis controlling the extent of mandibular advancement. Regression analysis showed that PNS advancement was independently associated with post-palatal airway expansion. Furthermore, MA+SPMA significantly reduced simulated airway resistance and airflow velocity, particularly in the post-palatal region, whereas MA alone yielded no significant aerodynamic improvements. In the OSA subgroup, both groups achieved significant AHI reductions, with MA+SPMA demonstrating significantly greater improvement, although this finding should be interpreted as exploratory. No clinically significant adverse effects on nasolabial soft-tissue profile were observed in the MA+SPMA group. Conclusions: Adding SPMA to MA was associated with greater airway enlargement, improved aerodynamics, and potential functional benefits compared to MA alone, without compromising nasolabial soft-tissue profile. Our findings support MA+SPMA as a promising surgical alternative that may balance the airway and aesthetic outcomes in selected patients with skeletal Class II deformity. Future studies are warranted to confirm its functional benefits and identify airway risk factors across Class II patient subgroups to facilitate risk-stratified surgical decision-making.
- Open Access
- 21 September 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1892710
Case Report: Orthognathic surgery combined with distraction osteogenesis for severe obstructive sleep apnea secondary to unilateral temporomandibular joint ankylosis
This case report evaluates the efficacy of combined orthognathic surgery, distraction osteogenesis, and temporomandibular joint surgery for severe obstructive sleep apnea secondary to temporomandibular joint ankylosis. A 33-year-old female presented with right temporomandibular joint ankylosis, limited mouth opening, mandibular retrusion, facial asymmetry, severe OSA (AHI: 94 events/hour, LSaO 2 : 66%), and chronic cardiac insufficiency. Treatment included distraction osteogenesis with temporomandibular joint arthroplasty to improve mouth opening, facial symmetry, and airway dimensions, followed by bimaxillary orthognathic surgery (Le Fort I osteotomy and genioplasty) to optimize occlusion, facial esthetics, and airway patency. Outcomes were assessed using cephalometric analysis, airway analysis, and CBCT imaging. Significant improvement in mandibular retrusion (ANB angle) and facial symmetry was achieved. Occlusion, airway parameters (volume, AHI, oxygen saturation), and mouth opening improved over a 24-month treatment period. Vertical distraction osteogenesis via ramus osteotomy simultaneously increased ramus height and provided condylar reconstruction. Concurrent genioplasty contributed to the expansion of the pharyngeal airway and upper airway volume. This case demonstrates that a staged protocol combining orthognathic surgery, temporomandibular joint surgery, and distraction osteogenesis can yield favorable outcomes for severe OSA secondary to temporomandibular joint ankylosis. Validation in larger cohorts with longer follow-up is required.
- 21 September 2026
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 14, 1892710
Open AccessCase Report: Orthognathic surgery combined with distraction osteogenesis for severe obstructive sleep apnea secondary to unilateral temporomandibular joint ankylosis
This case report evaluates the efficacy of combined orthognathic surgery, distraction osteogenesis, and temporomandibular joint surgery for severe obstructive sleep apnea secondary to temporomandibular joint ankylosis. A 33-year-old female presented with right temporomandibular joint ankylosis, limited mouth opening, mandibular retrusion, facial asymmetry, severe OSA (AHI: 94 events/hour, LSaO 2 : 66%), and chronic cardiac insufficiency. Treatment included distraction osteogenesis with temporomandibular joint arthroplasty to improve mouth opening, facial symmetry, and airway dimensions, followed by bimaxillary orthognathic surgery (Le Fort I osteotomy and genioplasty) to optimize occlusion, facial esthetics, and airway patency. Outcomes were assessed using cephalometric analysis, airway analysis, and CBCT imaging. Significant improvement in mandibular retrusion (ANB angle) and facial symmetry was achieved. Occlusion, airway parameters (volume, AHI, oxygen saturation), and mouth opening improved over a 24-month treatment period. Vertical distraction osteogenesis via ramus osteotomy simultaneously increased ramus height and provided condylar reconstruction. Concurrent genioplasty contributed to the expansion of the pharyngeal airway and upper airway volume. This case demonstrates that a staged protocol combining orthognathic surgery, temporomandibular joint surgery, and distraction osteogenesis can yield favorable outcomes for severe OSA secondary to temporomandibular joint ankylosis. Validation in larger cohorts with longer follow-up is required.
- Open Access
- 22 July 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
PF4 drives mechanical overload-induced temporomandibular joint osteoarthritis through TLR2-dependent activation of NF-κB
Mechanical overload‑related cytokines contribute to temporomandibular joint osteoarthritis (TMJOA) pathogenesis. This study investigated the role of
- 22 July 2026
- Published by Springer Nature in Journal of Translational Medicine
- Vol. 24 (1)
Open AccessPF4 drives mechanical overload-induced temporomandibular joint osteoarthritis through TLR2-dependent activation of NF-κB
Mechanical overload‑related cytokines contribute to temporomandibular joint osteoarthritis (TMJOA) pathogenesis. This study investigated the role of
- 6 February 2026
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 54 (5) , 104483
Clinical analysis and management of bone non-union after Le Fort I maxillary osteotomy: An 8-year retrospective study
- 6 February 2026
- Published by Elsevier in Journal of Cranio-Maxillofacial Surgery
- Vol. 54 (5) , 104483
Clinical analysis and management of bone non-union after Le Fort I maxillary osteotomy: An 8-year retrospective study
- Open Access
- 7 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (14) , 13889-13905
Nanosized Shikonin Disrupts Tumor-Cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy
Head and neck squamous cell carcinoma (HNSCC) frequently develops resistance to immune checkpoint blockade (ICB) therapy, resulting from an immune-excluded microenvironment. Immunogenic cell death (ICD) can increase tumor immunogenicity and further augment immune-cell infiltration by releasing immunogenic molecules. Hence, inducing ICD within tumors might be a promising strategy to restore antitumor immunity and sensitize HNSCC to ICB. Herein, we developed shikonin (SHK)-loaded, CGKRK-modified lipid nanoparticles (C-SNPs) and demonstrated that C-SNPs could enrich in tumor cells and induce necroptosis in vitro and in vivo. Transcriptomic profiling revealed that C-SNPs suppressed tumor-cell mismatch repair, which later activated the cGAS-mediated IFN response and further increased the expression of PD-L1. Combining C-SNPs with an anti-PD-1 antibody increased the infiltration of DCs and CD8+ T cells, yet the response was limited. Modifying C-SNPs with Mn2+ (C-SMNPs) enhanced the activation of cGAS-STING signaling and further boosted the maturation of DCs and the differentiation of cytotoxic T cells within ICB-treated tumors. Importantly, compared to C-SNPs, the combination of C-SMNPs with ICB resulted in more sustained tumor suppression in vivo. Together, we developed a versatile nanoparticle that delivered SHK and Mn2+ which sensitized HNSCC to ICB by disrupting tumor-cell mismatch repair and boosting the cGAS-STING-mediated IFN response. This nanosized ICD inducer-based strategy holds therapeutic potential in synergizing with anti-PD-1 immunotherapy to enhance treatment efficacy in HNSCC.
- 7 April 2025
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 19 (14) , 13889-13905
Open AccessNanosized Shikonin Disrupts Tumor-Cell Mismatch Repair and Synergizes with Manganese to Sensitize Squamous Carcinoma to Immunotherapy
Head and neck squamous cell carcinoma (HNSCC) frequently develops resistance to immune checkpoint blockade (ICB) therapy, resulting from an immune-excluded microenvironment. Immunogenic cell death (ICD) can increase tumor immunogenicity and further augment immune-cell infiltration by releasing immunogenic molecules. Hence, inducing ICD within tumors might be a promising strategy to restore antitumor immunity and sensitize HNSCC to ICB. Herein, we developed shikonin (SHK)-loaded, CGKRK-modified lipid nanoparticles (C-SNPs) and demonstrated that C-SNPs could enrich in tumor cells and induce necroptosis in vitro and in vivo. Transcriptomic profiling revealed that C-SNPs suppressed tumor-cell mismatch repair, which later activated the cGAS-mediated IFN response and further increased the expression of PD-L1. Combining C-SNPs with an anti-PD-1 antibody increased the infiltration of DCs and CD8+ T cells, yet the response was limited. Modifying C-SNPs with Mn2+ (C-SMNPs) enhanced the activation of cGAS-STING signaling and further boosted the maturation of DCs and the differentiation of cytotoxic T cells within ICB-treated tumors. Importantly, compared to C-SNPs, the combination of C-SMNPs with ICB resulted in more sustained tumor suppression in vivo. Together, we developed a versatile nanoparticle that delivered SHK and Mn2+ which sensitized HNSCC to ICB by disrupting tumor-cell mismatch repair and boosting the cGAS-STING-mediated IFN response. This nanosized ICD inducer-based strategy holds therapeutic potential in synergizing with anti-PD-1 immunotherapy to enhance treatment efficacy in HNSCC.
- Open Access
Controlled and Sequential Delivery of Stromal Derived Factor-1 α (SDF-1α) and Magnesium Ions from Bifunctional Hydrogel for Bone Regeneration
Bone healing is a complex process that requires the participation of cells and bioactive factors. Stromal derived factor-1 α (SDF-1α) and magnesium ions (Mg2+) both are significant bioactive factors for cell recruitment and osteogenesis during bone regeneration. Thus, a bifunctional hydrogel containing a sequential delivery system is fabricated to improve osteogenesis. During sequential delivery of the hydrogel, SDF-1α is predominantly released at the early stage of bone mesenchymal stem cells (BMSCs) recruitment, while Mg2+ are constantly delivered at a later stage to improve osteogenic differentiation of recruited cells. In addition, due to the early release of SDF-1α, the hydrogel showed strong BMSCs recruitment and proliferation activity. Mg2+ can not only induce up-regulation of osteogenic gene expression in vitro, but also promote bone tissue and angiogenesis in vivo. Taken together, the injection of xanthan gum-polydopamine crosslinked hydrogel co-loading SDF-1α and Mg2+ (XPMS hydrogel) provides a novel strategy to repair bone defects.
Open AccessControlled and Sequential Delivery of Stromal Derived Factor-1 α (SDF-1α) and Magnesium Ions from Bifunctional Hydrogel for Bone Regeneration
Bone healing is a complex process that requires the participation of cells and bioactive factors. Stromal derived factor-1 α (SDF-1α) and magnesium ions (Mg2+) both are significant bioactive factors for cell recruitment and osteogenesis during bone regeneration. Thus, a bifunctional hydrogel containing a sequential delivery system is fabricated to improve osteogenesis. During sequential delivery of the hydrogel, SDF-1α is predominantly released at the early stage of bone mesenchymal stem cells (BMSCs) recruitment, while Mg2+ are constantly delivered at a later stage to improve osteogenic differentiation of recruited cells. In addition, due to the early release of SDF-1α, the hydrogel showed strong BMSCs recruitment and proliferation activity. Mg2+ can not only induce up-regulation of osteogenic gene expression in vitro, but also promote bone tissue and angiogenesis in vivo. Taken together, the injection of xanthan gum-polydopamine crosslinked hydrogel co-loading SDF-1α and Mg2+ (XPMS hydrogel) provides a novel strategy to repair bone defects.
- 1 August 2021
- Published by Wiley in Small Methods
- Vol. 5 (9) , 2100536
Scaffold 3D‐Printed from Metallic Nanoparticles‐Containing Ink Simultaneously Eradicates Tumor and Repairs Tumor‐Associated Bone Defects
Bone metastasis occurs in about 70% of breast cancer patients. The surgical resection of metastatic tumors often leads to bone erosion and destruction, which greatly hinders the treatment and prognosis of breast cancer patients with bone metastasis. Herein, a bifunctional scaffold 3D‐printed from nanoink is fabricated to simultaneously eliminate the tumor cells and repair the tumor‐associated bone defects. The metallic polydopamine (PDA) nanoparticles (FeMg‐NPs) may effectively load and sustainably release the metal ions Fe3+ and Mg2+ in situ. Fe3+ exerts a chemodynamic therapy to synergize with the photothermal therapy induced by PDA with effective photothermal conversion under NIR laser, which efficiently eliminates the bone‐metastatic tumor. Meanwhile, the sustained release of osteoinductive Mg2+ from the bony porous 3D scaffold enhances the new bone formation in the bone defects. Taken together, the implantation of scaffold (FeMg‐SC) 3D‐printed from the FeMg‐NPs‐containing nanoink provides a novel strategy to simultaneously eradicate bone‐metastatic tumor and repair the tumor‐associated bone defects.
- 1 August 2021
- Published by Wiley in Small Methods
- Vol. 5 (9) , 2100536
Scaffold 3D‐Printed from Metallic Nanoparticles‐Containing Ink Simultaneously Eradicates Tumor and Repairs Tumor‐Associated Bone Defects
Bone metastasis occurs in about 70% of breast cancer patients. The surgical resection of metastatic tumors often leads to bone erosion and destruction, which greatly hinders the treatment and prognosis of breast cancer patients with bone metastasis. Herein, a bifunctional scaffold 3D‐printed from nanoink is fabricated to simultaneously eliminate the tumor cells and repair the tumor‐associated bone defects. The metallic polydopamine (PDA) nanoparticles (FeMg‐NPs) may effectively load and sustainably release the metal ions Fe3+ and Mg2+ in situ. Fe3+ exerts a chemodynamic therapy to synergize with the photothermal therapy induced by PDA with effective photothermal conversion under NIR laser, which efficiently eliminates the bone‐metastatic tumor. Meanwhile, the sustained release of osteoinductive Mg2+ from the bony porous 3D scaffold enhances the new bone formation in the bone defects. Taken together, the implantation of scaffold (FeMg‐SC) 3D‐printed from the FeMg‐NPs‐containing nanoink provides a novel strategy to simultaneously eradicate bone‐metastatic tumor and repair the tumor‐associated bone defects.
- 12 November 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (12) , 8627-8639
Promoted Bone Regeneration by 3D-Printed Porous Scaffolds with the Synergy of a Nanotopological Morphology and Amino Modification
Three-dimensional (3D)-printed scaffolds have great advantages for bone repair, and the combination of physical and chemical modifications of the surface can improve deficient biological properties to promote bone regeneration. In this study, a nanotopological morphology and an amino group were introduced into scaffold surfaces in sequence by alkaline solution and amination, respectively. The surface properties and the ability for osteogenic induction were investigated. The nanotopological morphology of the surface slightly enhanced the hydrophilic property of the material, while amination obviously increased the hydrophilicity of the surface. The aminated surface improved cell adhesion and proliferation, while the nanotopological morphology was able to facilitate the spread of stem cells, pseudopod extension, and osteogenic differentiation by changing the cell skeleton. The study confirmed that a nanotopological morphology and an amino group can play synergistic roles in improving the osteogenic efficiency and hydrophilicity, which was also confirmed in vivo by showing that effective surface modification of polylactic acid scaffolds enhanced high-quality bone formation, thus demonstrating great potential for clinical applications. The results indicate that scaffolds with the synergy of a nanotopological morphology and amino modification improve the osteogenic induction ability of scaffolds.
- 12 November 2020
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 3 (12) , 8627-8639
Promoted Bone Regeneration by 3D-Printed Porous Scaffolds with the Synergy of a Nanotopological Morphology and Amino Modification
Three-dimensional (3D)-printed scaffolds have great advantages for bone repair, and the combination of physical and chemical modifications of the surface can improve deficient biological properties to promote bone regeneration. In this study, a nanotopological morphology and an amino group were introduced into scaffold surfaces in sequence by alkaline solution and amination, respectively. The surface properties and the ability for osteogenic induction were investigated. The nanotopological morphology of the surface slightly enhanced the hydrophilic property of the material, while amination obviously increased the hydrophilicity of the surface. The aminated surface improved cell adhesion and proliferation, while the nanotopological morphology was able to facilitate the spread of stem cells, pseudopod extension, and osteogenic differentiation by changing the cell skeleton. The study confirmed that a nanotopological morphology and an amino group can play synergistic roles in improving the osteogenic efficiency and hydrophilicity, which was also confirmed in vivo by showing that effective surface modification of polylactic acid scaffolds enhanced high-quality bone formation, thus demonstrating great potential for clinical applications. The results indicate that scaffolds with the synergy of a nanotopological morphology and amino modification improve the osteogenic induction ability of scaffolds.
- 14 March 2015
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 103 (10) , 3226-3236
Osteogenesis and chondrogenesis of biomimetic integrated porous PVA/gel/V-n-HA/pa6 scaffolds and BMSCs construct in repair of articular osteochondral defect
A novel bi‐layered osteochondral scaffold, including of PVA/Gel/V layer for the cartilage and n‐HA/PA6 layer for the subchondral bone, has been proposed to evaluate the potential of the engineered of osteochondral grafts in repairing articular osteochondral defects in rabbits. The two different layers of the scaffolds were seeded with allogenic bone marrow‐derived stem cells (BMSCs), which were chondrogenically and osteogenically induced respectively. The critical‐size osteochondral defects were created in the knees of adult rabbits. The defects were treated with cell‐bi‐layered constructs (Group A), bi‐layered constructs (Group B) and untreated group C as control group. The adhesion, proliferation and differentiation of BMSCs were demonstrated by immunohistochemical staining and scanning electron microscopy (SEM) in vitro. Cell survival was tracked via fluorescent labeling in vivo. Overall, the porous PVA/Gel/V‐n‐HA/PA6 scaffold was compatible and had no negative effects on the BMSCs in vitro culture. The cell‐bi‐layered scaffolds showed superior repair results as compared to the control group using gross examination and histological assessment. With BMSCs implantation, the two different layers of the composite biomimetic scaffolds provided a suitable environment for cells to form respective tissue. Simultaneously, the RT‐PCR results confirmed the expression of specific extracellular matrix (ECM) markers for cartilaginous or osteoid tissue. This investigation showed that the porous PVA/Gel/V‐n‐HA/PA6 scaffold is a potential matrix for treatment of osteochondral defects, and the method of using chondrogenically and osteogenically differentiated BMSCs as seed cells on each layer might be a promising strategy in repair of articular osteochondral defect due to enhanced chondrogenesis and osteogenesis. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3226–3236, 2015.
- 14 March 2015
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 103 (10) , 3226-3236
Osteogenesis and chondrogenesis of biomimetic integrated porous PVA/gel/V-n-HA/pa6 scaffolds and BMSCs construct in repair of articular osteochondral defect
A novel bi‐layered osteochondral scaffold, including of PVA/Gel/V layer for the cartilage and n‐HA/PA6 layer for the subchondral bone, has been proposed to evaluate the potential of the engineered of osteochondral grafts in repairing articular osteochondral defects in rabbits. The two different layers of the scaffolds were seeded with allogenic bone marrow‐derived stem cells (BMSCs), which were chondrogenically and osteogenically induced respectively. The critical‐size osteochondral defects were created in the knees of adult rabbits. The defects were treated with cell‐bi‐layered constructs (Group A), bi‐layered constructs (Group B) and untreated group C as control group. The adhesion, proliferation and differentiation of BMSCs were demonstrated by immunohistochemical staining and scanning electron microscopy (SEM) in vitro. Cell survival was tracked via fluorescent labeling in vivo. Overall, the porous PVA/Gel/V‐n‐HA/PA6 scaffold was compatible and had no negative effects on the BMSCs in vitro culture. The cell‐bi‐layered scaffolds showed superior repair results as compared to the control group using gross examination and histological assessment. With BMSCs implantation, the two different layers of the composite biomimetic scaffolds provided a suitable environment for cells to form respective tissue. Simultaneously, the RT‐PCR results confirmed the expression of specific extracellular matrix (ECM) markers for cartilaginous or osteoid tissue. This investigation showed that the porous PVA/Gel/V‐n‐HA/PA6 scaffold is a potential matrix for treatment of osteochondral defects, and the method of using chondrogenically and osteogenically differentiated BMSCs as seed cells on each layer might be a promising strategy in repair of articular osteochondral defect due to enhanced chondrogenesis and osteogenesis. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 3226–3236, 2015.